Jay S. Duker, Director at EyePoint Pharmaceuticals, Inc. (EYPT), bought 5,000 shares at $1.89 ($9K) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market purchase of $9k EYPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.